Effects of angiotensin Ⅱ receptor antagonist on TGF-β1 synthesis and TIMP-1 mRNA expression of hepatic stellate cells / 国际外科学杂志
International Journal of Surgery
; (12): 600-602, 2010.
Article
en Zh
| WPRIM
| ID: wpr-387354
Biblioteca responsable:
WPRO
ABSTRACT
Objective To investigate the effects of angiotensin Ⅱ (Ang Ⅱ ) and angiotensin Ⅱ type 1 receptor antagonist (AT1RA) on the transforming growth factor-β1 (TGF-β1) synthesis and tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNA expression of in vitro cultured hepatic stellate cells (HSCs). Methods HSC-T6 rat hepatic stellate cell line was selected as the study model of the activated hepatic stellate cells. Cultured HSCs were randomized into control group, Ang Ⅱ group, AT1RA group and Ang Ⅱ AT1RA group. Cell culture medium was used to detect the TGF-β1 level by ELISA method. HSCs were harvested to measure the TIMP-1 mRNA expression by RT-PCR. Results TGF-β1 level of control group, Ang Ⅱ group and AngⅡ AT1RA group in cell culture medium was (7.531 ±0. 654) pg/mL, (9. 855± 1. 485)pg/mL and (7.719 ± 0.329) pg/mL respectively, Ang Ⅱ group higher than control group (P < 0.05 ), Ang Ⅱ AT1RA group lower than Ang Ⅱ group (P < 0. 05 ). TIMP-1 mRNA expression level of control group, Ang Ⅱ group and Ang Ⅱ AT1RA group in HSCs was 3. 387 ± 0. 042, 4.870 ± 0.061 and 3. 837 ± 0. 042 respectively, Ang Ⅱ group higher than control group ( P < 0. 05 ), Ang Ⅱ AT1RA group lower than Ang Ⅱ group (P < 0. 05). Conclusion AngiotensinⅡ can increase the TGF-β1 synthesis and TIMP-1 mRNA expression of hepatic stellate cells, while all these effects are inhibited by angiotensinⅡ type 1 receptor antagonist.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Idioma:
Zh
Revista:
International Journal of Surgery
Año:
2010
Tipo del documento:
Article